Global Cell and Gene Therapy Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 133
Published Date: 03 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Cell and Gene Therapy Drug Delivery Devices market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cell and Gene Therapy Drug Delivery Devices industry chain, the market status of Luxturna (Sterile Insulin Syringe, Pre-Filled Syringe), Kymriah (Sterile Insulin Syringe, Pre-Filled Syringe), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy Drug Delivery Devices.
Regionally, the report analyzes the Cell and Gene Therapy Drug Delivery Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy Drug Delivery Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy Drug Delivery Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy Drug Delivery Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Sterile Insulin Syringe, Pre-Filled Syringe).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy Drug Delivery Devices market.
Regional Analysis: The report involves examining the Cell and Gene Therapy Drug Delivery Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy Drug Delivery Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cell and Gene Therapy Drug Delivery Devices:
Company Analysis: Report covers individual Cell and Gene Therapy Drug Delivery Devices players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy Drug Delivery Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Luxturna, Kymriah).
Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy Drug Delivery Devices. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy Drug Delivery Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy Drug Delivery Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cell and Gene Therapy Drug Delivery Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Sterile Insulin Syringe
Pre-Filled Syringe
Infusion Bags
Market segment by Application
Luxturna
Kymriah
Provenge
Zolgensma
Yescarta
Strimvelis
Market segment by players, this report covers
Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Drug Delivery Devices, with revenue, gross margin and global market share of Cell and Gene Therapy Drug Delivery Devices from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy Drug Delivery Devices competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy Drug Delivery Devices market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Drug Delivery Devices.
Chapter 13, to describe Cell and Gene Therapy Drug Delivery Devices research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Drug Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Drug Delivery Devices by Type
1.3.1 Overview: Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Type in 2023
1.3.3 Sterile Insulin Syringe
1.3.4 Pre-Filled Syringe
1.3.5 Infusion Bags
1.4 Global Cell and Gene Therapy Drug Delivery Devices Market by Application
1.4.1 Overview: Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Luxturna
1.4.3 Kymriah
1.4.4 Provenge
1.4.5 Zolgensma
1.4.6 Yescarta
1.4.7 Strimvelis
1.5 Global Cell and Gene Therapy Drug Delivery Devices Market Size & Forecast
1.6 Global Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region, (2019-2030)
1.6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2019-2030)
1.6.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2019-2030)
1.6.6 South America Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2019-2030)
2.1 Amgen, Inc.
2.1.1 Amgen, Inc. Details
2.1.2 Amgen, Inc. Major Business
2.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen, Inc. Recent Developments and Future Plans
2.2 Bausch and Lomb Incorporated
2.2.1 Bausch and Lomb Incorporated Details
2.2.2 Bausch and Lomb Incorporated Major Business
2.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bausch and Lomb Incorporated Recent Developments and Future Plans
2.3 Becton, Dickinson and Company
2.3.1 Becton, Dickinson and Company Details
2.3.2 Becton, Dickinson and Company Major Business
2.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans
2.4 Bluebird bio, Inc.
2.4.1 Bluebird bio, Inc. Details
2.4.2 Bluebird bio, Inc. Major Business
2.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bluebird bio, Inc. Recent Developments and Future Plans
2.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
2.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Details
2.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
2.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments and Future Plans
2.6 Dendreon Pharmaceuticals LLC.
2.6.1 Dendreon Pharmaceuticals LLC. Details
2.6.2 Dendreon Pharmaceuticals LLC. Major Business
2.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans
2.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
2.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Details
2.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
2.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments and Future Plans
2.8 Human Stem Cell Institute
2.8.1 Human Stem Cell Institute Details
2.8.2 Human Stem Cell Institute Major Business
2.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Human Stem Cell Institute Recent Developments and Future Plans
2.9 Kite Pharma, Inc.
2.9.1 Kite Pharma, Inc. Details
2.9.2 Kite Pharma, Inc. Major Business
2.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kite Pharma, Inc. Recent Developments and Future Plans
2.10 Kolon Tissue Gene, inc.
2.10.1 Kolon Tissue Gene, inc. Details
2.10.2 Kolon Tissue Gene, inc. Major Business
2.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Kolon Tissue Gene, inc. Recent Developments and Future Plans
2.11 Novartis AG
2.11.1 Novartis AG Details
2.11.2 Novartis AG Major Business
2.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Novartis AG Recent Developments and Future Plans
2.12 Orchard Therapeutics plc.
2.12.1 Orchard Therapeutics plc. Details
2.12.2 Orchard Therapeutics plc. Major Business
2.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Orchard Therapeutics plc. Recent Developments and Future Plans
2.13 Pfizer, Inc.
2.13.1 Pfizer, Inc. Details
2.13.2 Pfizer, Inc. Major Business
2.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Pfizer, Inc. Recent Developments and Future Plans
2.14 Renova Therapeutics
2.14.1 Renova Therapeutics Details
2.14.2 Renova Therapeutics Major Business
2.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Renova Therapeutics Recent Developments and Future Plans
2.15 Spark Therapeutics, Inc.
2.15.1 Spark Therapeutics, Inc. Details
2.15.2 Spark Therapeutics, Inc. Major Business
2.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Spark Therapeutics, Inc. Recent Developments and Future Plans
2.16 uniQure N.V.
2.16.1 uniQure N.V. Details
2.16.2 uniQure N.V. Major Business
2.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 uniQure N.V. Recent Developments and Future Plans
2.17 Vericel Corporation
2.17.1 Vericel Corporation Details
2.17.2 Vericel Corporation Major Business
2.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Solutions
2.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Vericel Corporation Recent Developments and Future Plans
3.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cell and Gene Therapy Drug Delivery Devices by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Drug Delivery Devices Players Market Share in 2023
3.2.3 Top 6 Cell and Gene Therapy Drug Delivery Devices Players Market Share in 2023
3.3 Cell and Gene Therapy Drug Delivery Devices Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Drug Delivery Devices Market: Region Footprint
3.3.2 Cell and Gene Therapy Drug Delivery Devices Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Drug Delivery Devices Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Cell and Gene Therapy Drug Delivery Devices Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Type (2025-2030)
5.1 Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Application (2019-2024)
5.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Application (2025-2030)
6.1 North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2030)
6.2 North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2030)
6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2030)
6.3.2 United States Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
6.3.3 Canada Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
6.3.4 Mexico Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
7.1 Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2030)
7.2 Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2030)
7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2030)
7.3.2 Germany Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
7.3.3 France Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
7.3.5 Russia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
7.3.6 Italy Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2019-2030)
8.3.2 China Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
8.3.3 Japan Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
8.3.4 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
8.3.5 India Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
8.3.7 Australia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
9.1 South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2030)
9.2 South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2030)
9.3 South America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
9.3.1 South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2030)
9.3.2 Brazil Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
9.3.3 Argentina Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2030)
10.3.2 Turkey Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
10.3.4 UAE Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2019-2030)
11.1 Cell and Gene Therapy Drug Delivery Devices Market Drivers
11.2 Cell and Gene Therapy Drug Delivery Devices Market Restraints
11.3 Cell and Gene Therapy Drug Delivery Devices Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Cell and Gene Therapy Drug Delivery Devices Industry Chain
12.2 Cell and Gene Therapy Drug Delivery Devices Upstream Analysis
12.3 Cell and Gene Therapy Drug Delivery Devices Midstream Analysis
12.4 Cell and Gene Therapy Drug Delivery Devices Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Amgen, Inc. Company Information, Head Office, and Major Competitors
Table 6. Amgen, Inc. Major Business
Table 7. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 8. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Amgen, Inc. Recent Developments and Future Plans
Table 10. Bausch and Lomb Incorporated Company Information, Head Office, and Major Competitors
Table 11. Bausch and Lomb Incorporated Major Business
Table 12. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 13. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bausch and Lomb Incorporated Recent Developments and Future Plans
Table 15. Becton, Dickinson and Company Company Information, Head Office, and Major Competitors
Table 16. Becton, Dickinson and Company Major Business
Table 17. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 18. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Becton, Dickinson and Company Recent Developments and Future Plans
Table 20. Bluebird bio, Inc. Company Information, Head Office, and Major Competitors
Table 21. Bluebird bio, Inc. Major Business
Table 22. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 23. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Bluebird bio, Inc. Recent Developments and Future Plans
Table 25. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Information, Head Office, and Major Competitors
Table 26. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
Table 27. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 28. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments and Future Plans
Table 30. Dendreon Pharmaceuticals LLC. Company Information, Head Office, and Major Competitors
Table 31. Dendreon Pharmaceuticals LLC. Major Business
Table 32. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 33. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans
Table 35. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Information, Head Office, and Major Competitors
Table 36. Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
Table 37. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 38. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments and Future Plans
Table 40. Human Stem Cell Institute Company Information, Head Office, and Major Competitors
Table 41. Human Stem Cell Institute Major Business
Table 42. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 43. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Human Stem Cell Institute Recent Developments and Future Plans
Table 45. Kite Pharma, Inc. Company Information, Head Office, and Major Competitors
Table 46. Kite Pharma, Inc. Major Business
Table 47. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 48. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Kite Pharma, Inc. Recent Developments and Future Plans
Table 50. Kolon Tissue Gene, inc. Company Information, Head Office, and Major Competitors
Table 51. Kolon Tissue Gene, inc. Major Business
Table 52. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 53. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Kolon Tissue Gene, inc. Recent Developments and Future Plans
Table 55. Novartis AG Company Information, Head Office, and Major Competitors
Table 56. Novartis AG Major Business
Table 57. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 58. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Novartis AG Recent Developments and Future Plans
Table 60. Orchard Therapeutics plc. Company Information, Head Office, and Major Competitors
Table 61. Orchard Therapeutics plc. Major Business
Table 62. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 63. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Orchard Therapeutics plc. Recent Developments and Future Plans
Table 65. Pfizer, Inc. Company Information, Head Office, and Major Competitors
Table 66. Pfizer, Inc. Major Business
Table 67. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 68. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Pfizer, Inc. Recent Developments and Future Plans
Table 70. Renova Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Renova Therapeutics Major Business
Table 72. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 73. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Renova Therapeutics Recent Developments and Future Plans
Table 75. Spark Therapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 76. Spark Therapeutics, Inc. Major Business
Table 77. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 78. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Spark Therapeutics, Inc. Recent Developments and Future Plans
Table 80. uniQure N.V. Company Information, Head Office, and Major Competitors
Table 81. uniQure N.V. Major Business
Table 82. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 83. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. uniQure N.V. Recent Developments and Future Plans
Table 85. Vericel Corporation Company Information, Head Office, and Major Competitors
Table 86. Vericel Corporation Major Business
Table 87. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Solutions
Table 88. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Vericel Corporation Recent Developments and Future Plans
Table 90. Global Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) by Players (2019-2024)
Table 91. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players (2019-2024)
Table 92. Breakdown of Cell and Gene Therapy Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Cell and Gene Therapy Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 94. Head Office of Key Cell and Gene Therapy Drug Delivery Devices Players
Table 95. Cell and Gene Therapy Drug Delivery Devices Market: Company Product Type Footprint
Table 96. Cell and Gene Therapy Drug Delivery Devices Market: Company Product Application Footprint
Table 97. Cell and Gene Therapy Drug Delivery Devices New Market Entrants and Barriers to Market Entry
Table 98. Cell and Gene Therapy Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value (USD Million) by Type (2019-2024)
Table 100. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Share by Type (2019-2024)
Table 101. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Forecast by Type (2025-2030)
Table 102. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2024)
Table 103. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Forecast by Application (2025-2030)
Table 104. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 105. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 106. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 107. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 108. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 109. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 110. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 111. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 112. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 113. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 114. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 117. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 118. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 119. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 120. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 121. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 122. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 123. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 124. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 125. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 126. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 127. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 129. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 130. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 131. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 132. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 133. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 134. Cell and Gene Therapy Drug Delivery Devices Raw Material
Table 135. Key Suppliers of Cell and Gene Therapy Drug Delivery Devices Raw Materials
List of Figures
Figure 1. Cell and Gene Therapy Drug Delivery Devices Picture
Figure 2. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Type in 2023
Figure 4. Sterile Insulin Syringe
Figure 5. Pre-Filled Syringe
Figure 6. Infusion Bags
Figure 7. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Application in 2023
Figure 9. Luxturna Picture
Figure 10. Kymriah Picture
Figure 11. Provenge Picture
Figure 12. Zolgensma Picture
Figure 13. Yescarta Picture
Figure 14. Strimvelis Picture
Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Cell and Gene Therapy Drug Delivery Devices Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 18. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Region in 2023
Figure 20. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 25. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players in 2023
Figure 26. Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 27. Global Top 3 Players Cell and Gene Therapy Drug Delivery Devices Market Share in 2023
Figure 28. Global Top 6 Players Cell and Gene Therapy Drug Delivery Devices Market Share in 2023
Figure 29. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Share by Type (2019-2024)
Figure 30. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Type (2025-2030)
Figure 31. Global Cell and Gene Therapy Drug Delivery Devices Consumption Value Share by Application (2019-2024)
Figure 32. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Application (2025-2030)
Figure 33. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Type (2019-2030)
Figure 34. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Application (2019-2030)
Figure 35. North America Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 43. France Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Region (2019-2030)
Figure 50. China Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 53. India Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 56. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Type (2019-2030)
Figure 57. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Application (2019-2030)
Figure 58. South America Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 67. Cell and Gene Therapy Drug Delivery Devices Market Drivers
Figure 68. Cell and Gene Therapy Drug Delivery Devices Market Restraints
Figure 69. Cell and Gene Therapy Drug Delivery Devices Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Drug Delivery Devices in 2023
Figure 72. Manufacturing Process Analysis of Cell and Gene Therapy Drug Delivery Devices
Figure 73. Cell and Gene Therapy Drug Delivery Devices Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Amgen, Inc. Bausch and Lomb Incorporated Becton, Dickinson and Company Bluebird bio, Inc. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Dendreon Pharmaceuticals LLC. Helixmith Co., Ltd (ViroMed Co., Ltd) Human Stem Cell Institute Kite Pharma, Inc. Kolon Tissue Gene, inc. Novartis AG Orchard Therapeutics plc. Pfizer, Inc. Renova Therapeutics Spark Therapeutics, Inc. uniQure N.V. Vericel Corporation
Related Reports
10 Jan 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
